AB1088 EARLY CLINICAL IMPROVEMENT AS PREDICTOR OF LONG-TERM HEALTH-RELATED QUALITY OF LIFE IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH GUSELKUMAB: POST-HOC ANALYSIS THROUGH 2 YEARS OF A PHASE-3 STUDY

Abstract

BackgroundPatients (pts) with psoriatic arthritis (PsA) experience lower quality of life than both the general population and pts with psoriasis alone[1,2]. Recent PsA treatment recommendations highlight the importance of maximizing...